Chat with us
Research Assistance
Online
  • Please enter your first name.

Switzerland In Vitro Fertilization Market Size & Outlook

The in vitro fertilization market in Switzerland is expected to reach a projected revenue of US$ 464.6 million by 2033. A compound annual growth rate of 5.07% is expected of Switzerland in vitro fertilization market from 2026 to 2033.
Revenue, 2025 (US$M)
$309.6
Estimate, 2026 (US$M)
$328.8
Forecast, 2033 (US$M)
$464.6
CAGR, 2026 - 2033
5.1%
Switzerland In Vitro Fertilization Market, 2021-2033 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Switzerland in vitro fertilization market highlights

  • The Switzerland in vitro fertilization market generated a revenue of USD 309.6 million in 2025 and is expected to reach USD 464.6 million by 2033.
  • The Switzerland market is expected to grow at a CAGR of 5.07% from 2026 to 2033.
  • In terms of segment, frozen nondonor was the largest revenue generating procedure type in 2025.
  • Frozen Nondonor is the most lucrative procedure type segment registering the fastest growth during the forecast period.


In vitro fertilization market data book summary

Market revenue in 2025USD 309.6 million
Market revenue in 2033USD 464.6 million
Growth rate5.07% (CAGR from 2026 to 2033)
Largest segmentFrozen nondonor
Fastest growing segmentFrozen Nondonor
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationFresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor
Key market players worldwideBayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility


Other key industry trends

  • In terms of revenue, Switzerland accounted for 1.1% of the global in vitro fertilization market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Europe, Germany in vitro fertilization market is projected to lead the regional market in terms of revenue in 2033.
  • Germany is the fastest growing regional market in Europe and is projected to reach USD 2,608.0 million by 2033.

According to the Federal Statistical Office, the number of children born in Switzerland through the utilization of ART, specifically IVF, increased by 13% in 2021 compared to the previous year. The data indicates that approximately 2,500 children were born as a result of IVF treatments during that period.

In addition, in around 35% of cases, infertility was attributed to the man, while in approximately 27% of cases, the woman was identified as the cause of infertility. In the remaining instances, either both partners had infertility issues or the cause of infertility remained unclear.

Furthermore, Switzerland attracts some medical tourists seeking IVF treatments due to its reputation for high-quality healthcare services. Factors such as the expertise of Swiss fertility specialists and the country's scenic locations contribute to its appeal.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Three ways to get this data

Subscribe to the databook, customize it, or ask a question.

Horizon Databook

Unlock every chart on this page and get dashboard access

  • Statistics1.2M+ across all markets
  • Databooks30K+ global, 120K+ country
  • Companies200K+ profiles
  • ExportPDF, Dashboard, XLS & PNG, licensed to cite

Ask Prism AI

A cited answer in seconds

  • Corpus30,000 studies, 1.2M points
  • ScopeAll markets, not just this
  • CitationTraced to report & table
  • HonestySays "not covered" if so
  • SpeedSeconds, not days
ISO 9001 & 27001 certifiedESOMAR memberNot sure which fits? Call +1-415-854-0727

In Vitro Fertilization Market Companies

NameProfile# EmployeesHQWebsite
Merck KGaAView profile 62,345Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293www.emdgroup.com
Boston Scientific CorpView profile 48,000300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234www.bostonscientific.com
Vitrolife AB ADRView profile 1,116Box 9080, Gothenburg, Sweden, 400 92www.vitrolife.com
FUJIFILM Holdings CorpView profile 83,7847-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052www.fujifilmholdings.com
Thermo Fisher Scientific IncView profile 122,000168 Third Avenue, Waltham, MA, United States, 02451www.thermofisher.com
Merck & Co IncView profile 72,000126 East Lincoln Avenue, Rahway, NJ, United States, 07065www.merck.com
The Cooper Companies IncView profile 15,0006101 Bollinger Canyon Road, Suite 500, San Ramon, CA, United States, 94583www.coopercos.com
Genea BiomedxView profile 101-250Sydney, New South Wales, Australia, Oceaniawww.geneabiomedx.com
Bayer AGView profile 99,723Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368www.bayer.com
Cook MedicalView profile 10001+Bloomington, Indiana, United States, North Americawww.cookmedical.com

Switzerland In Vitro Fertilization Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to In Vitro Fertilization Market Outlook will help companies and investors design strategic landscapes.


Frozen Nondonor was the largest segment with a revenue share of 51.74% in 2025.

Horizon Databook has segmented the Switzerland in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2021 to 2033.




According to the Federal Statistical Office, the number of children born in Switzerland through the utilization of ART, specifically IVF, increased by 13% in 2021 compared to the previous year. The data indicates that approximately 2,500 children were born as a result of IVF treatments during that period.

In addition, in around 35% of cases, infertility was attributed to the man, while in approximately 27% of cases, the woman was identified as the cause of infertility. In the remaining instances, either both partners had infertility issues or the cause of infertility remained unclear.

Furthermore, Switzerland attracts some medical tourists seeking IVF treatments due to its reputation for high-quality healthcare services. Factors such as the expertise of Swiss fertility specialists and the country's scenic locations contribute to its appeal.

  • Switzerland In Vitro Fertilization Market Procedure Type Outlook (Revenue, USD Million , 2021-2033)
    • Fresh Nondonor
    • Frozen Nondonor
    • Fresh Donor
    • Frozen Donor
  • Switzerland In Vitro Fertilization Market Providers Outlook (Revenue, USD Million , 2021-2033)
    • Fertility Clinics
    • Hospitals and Other Settings

Reasons to subscribe to In Vitro Fertilization Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of In Vitro Fertilization Market Outlook databook

  • Our clientele includes a mix of In Vitro Fertilization Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Switzerland In Vitro Fertilization Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Switzerland In Vitro Fertilization Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Switzerland In Vitro Fertilization Market, 2021-2033 (US$M)

No Access Stack Chart

Switzerland in vitro fertilization market statistics, by procedure type, 2021-2033 (US$M)

No Access Pie Chart

Switzerland in vitro fertilization market statistics, by procedure type, 2021-2033 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more